Newsroom

HELSINKI--(BUSINESS WIRE)--Coolbrook secures Business Finland funding to accelerate electrification for the global steel industry...

HAMBURG, Deutschland--(BUSINESS WIRE)--KAYTUS, ein führender Anbieter von KI-Infrastruktur und Flüssigkeitskühlungslösungen, hat auf der ISC 2026 zwei zentrale Lösungen für KI-Rechenzentren der nächsten Generation vorgestellt: eine vollständig vorgefertigte, containerisierte und flüssigkeitsgekühlte Rechenzentrumslösung im Gigawatt-Maßstab sowie KSManage Ultra, eine intelligente Betriebsmanagement-Plattform für AI Factories. Gemeinsam erfüllen die Lösungen die steigenden Anforderungen an Effizi...

新加坡--(BUSINESS WIRE)--(美国商业资讯)-- 作为柬埔寨籍人士Leak Yim先生及其家人的法律顾问，Seiden Law LLP (“Seiden Law”)宣布，已在美国华盛顿特区的联邦地区法院提交申请，请求法院下令进行证据开示，以查明可能导致Yim先生在泰国被错误起诉，以及他被不当指认与亚洲诈骗中心有关联并上报给美国国会的虚假和误导性信息。 《美国法典》第28卷第1782条（简称“1782条款”）提供了强有力的证据收集救济途径，允许申请人在美国获取证据以协助国际诉讼程序。Seiden Law是一家在1782条款案件方面拥有丰富经验的美国律师事务所，此次提交申请旨在强制要求美国境内的相关人员提交文件并提供宣誓证词，以查明近期针对Yim先生的起诉背后的真相。 Seiden Law管理合伙人兼Yim先生的维权首席代理律师Robert Seiden表示：“Yim先生和他的年轻家庭显然是连带定罪和政治迫害的受害者。” 正如1782条款申请中所证实的那样，自2025年9月以来，这场抹黑Yim先生及其家人的全球性活动，是由媒体机构和记者与泰国政府串通推动的。 Seiden补...

SHEFFIELD, England--(BUSINESS WIRE)--Iceotope, the global pioneer in precision liquid cooling for AI infrastructure, has been named the winner of the Best HPC Cooling Innovation category for the 2026 Nimbus Innovation Awards – HPC Edition.The award recognizes innovations that advance the industry's ability to address the growing thermal management demands of high-performance computing (HPC) and AI infrastructure. Winners are selected by the editors of the Nimbus Alliance member publications, whi...

LONDON--(BUSINESS WIRE)--  PRE-STABILISATION ANNOUNCEMENT Date: 29th June 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. Compagnie de financement foncier Pre-stabilisation Period Announcement Natixis (contact: Christopher Agathangelou; telephone: 0158550814) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following sec...

LONDON--(BUSINESS WIRE)--  PRE-STABILISATION ANNOUNCEMENT Date: 29th June 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. Compagnie de financement foncier Pre-stabilisation Period Announcement Natixis (contact: Christopher Agathangelou; telephone: 0158550814) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following sec...

INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and...

MILAN--(BUSINESS WIRE)--Zambon kondigde vandaag aan dat het Comité voor Geneesmiddelen voor Menselijk Gebruik (CHMP) een positief advies heeft aangenomen waarin het Europees Geneesmiddelenagentschap (EMA) wordt aanbevolen een handelsvergunning te verlenen voor Hopledo® (gewijzigde afgifte levodopa/carbidopa) voor de behandeling van volwassen patiënten met de ziekte van Parkinson en matige tot ernstige motorische fluctuaties die niet voldoende gestabiliseerd zijn met orale behandelregimes op bas...

MILANO--(BUSINESS WIRE)--Zambon ha annunciato oggi che il Committee for Medicinal Products for Human Use (CHMP – Comitato per i Medicinali per Uso Umano) ha espresso parere favorevole, raccomandando all’Agenzia europea per i medicinali (EMA) il rilascio dell’autorizzazione all’immissione in commercio di Hopledo® (levodopa/carbidopa a rilascio modificato) per il trattamento di pazienti adulti affetti da Malattia di Parkinson con fluttuazioni motorie da moderate a severe, non sufficientemente sta...

MILAN--(BUSINESS WIRE)--Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations....